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ABSTRACT
Type 1 diabetes mellitus (T1DM) is considered as an autoimmune disease. It is 
characterised by the presence of antibody (humoral) and T-cell (cellular) responses to 
islet proteins (antigens). Nigella sativa oil and its major component thymoquinone (TQ) 
have been documented to have hypoglycemic properties in both type 1 and type 2 
diabetes, but to the best of our knowledge the effect of this plant on the 
immunopathology of IDDM has never been examined.The objectives of this study were 
to determine the potential immunomodulatory effect of administration of Nigella sativa 
oil and it major compound thymoquinone (TQ) in the disease process of IDDM by 
assessing the levels of anti- islet cell antibodies, pan T- lymphocytes marker (CD90), pan 
B-lymphocytes markers (CD19), and pan innate cells marker (CD 1 lb).Method: Type 1 
diabetic state was induced to overnight fasted animals by intraperitoneal injection with a 
single dose of STZ (65 mg/kg body weight). Six equal sized groups of male Sprague- 
Dawley rats received or not different doses of N. sativa oil and TQ. Blood glucose was 
tested every morning through 30 days of the experimental period. After completion of the 
4 weeks experimental protocols, blood samples were collected from overnight fasted rats 
by the cardiac puncture under anesthesia. Serum was assayed for autoimmune anti- Islet 
cell antibodies (ICA), pan T- lymphocytes marker (CD90), pan B-lymphocytes marker 
(CD 19), and pan innate cells marker (CD1 lb) in addition to serum insulin using enzyme- 
linked immunosorbent assay (ELISA) . The animals were dissected after sacrificed and 
the pancreas was taken for histology. This organ was placed in 10% formalin for fixation. 
Results: T1DM causesincreased the levels of serum glucose, levels of T, B lymphocytes 
markers, innate cells marker, and ICA and decreased serum insulin level, meanwhile 
treatment of diabetic rats with N. sativa oil and TQ significantly decrease the levels of all 
immunological (p< 0.05) beside it significantly resulted in elevation of serum insulin 
level (p< 0.05). The study also emphasized that, N. sativa oil and TQ are effective against 
STZ diabetes as its administration ameliorated most of the pathological 
changes.Conclusions: These experimental results indicate the immunomodulatory effect 
of N.sativa against autoimmune reactions occurs in T1DM. This data provide new 
strategies for using this plant to be recommended in the clinical management, control, 
and prevention of T1DM. Moreover, N. sativa oil and TQ may be suggested to be used in 
the management of other autoimmune diseases.
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CHAPTER ONE
INTRODUCTION
1.1 GENERAL INTRODUCTION
Diabetes mellitus (DM) is commonly considered as a metabolic disease of the 
endocrine system, resulting from either insufficient production or insufficient action of 
insulin (American Diabetes Association, 2010). The DM has a tremendous impact not 
only on health of individuals but also on health care around the world. It encompasses a 
family of disorders of carbohydrate metabolism disease that are characterized by 
hyperglycaemia and the development of long-term macro vascular, microvascular, 
neuropathic and retinopathy complications (Ganesan et al., 2011). Diabetes mellitus and 
its complications are one of the common causes of death in the developing countries. The 
prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in the year 
2000 and 4.4% in the year 2030 (Sarah et al., 2004). From the World Health 
Organization (WHO) reports, about 10% of people are suffering from typel diabetes 
whilst 90% of people are type 2 sufferers. The summary of estimated numbers of people 
with diabetes in the different regions for the year 2000 and 2030 is shown in Table 1.1.
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